Connecting you to content on EBSCOhost

Works by Uhrenholt, Line

Results: 6

1

Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis: a systematic review and meta-analysis.

Published in:

Rheumatology, 2022, v. 61, n. 8, p. 3107, doi. 10.1093/rheumatology/keab902

By:

Uhrenholt, Line;
Christensen, Robin;
Dinesen, Wilfred K H;
Liboriussen, Caroline H;
Andersen, Stine S;
Dreyer, Lene;
Schlemmer, Annette;
Hauge, Ellen-Margrethe;
Skrubbeltrang, Conni;
Taylor, Peter C;
Kristensen, Salome

Publication type:

Article

2

Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark.

Published in:

Rheumatology, 2021, v. 60, p. SI59, doi. 10.1093/rheumatology/keaa897

By:

Cordtz, René;
Lindhardsen, Jesper;
Soussi, Bolette G;
Vela, Jonathan;
Uhrenholt, Line;
Westermann, Rasmus;
Kristensen, Salome;
Nielsen, Henrik;
Torp-Pedersen, Christian;
Dreyer, Lene

Publication type:

Article

3

Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study.

Published in:

Lupus, 2021, v. 30, n. 13, p. 2124, doi. 10.1177/09612033211051641

By:

Uhrenholt, Line;
Høstgaard, Simone;
Pedersen, Julie F;
Christensen, Robin;
Dreyer, Lene;
Leffers, Henrik C B;
Taylor, Peter C;
Strand, Vibeke;
Jacobsen, Søren;
Voss, Anne;
Gregersen, Jon W;
Kristensen, Salome

Publication type:

Article

4

Predicting successful biologics tapering in patients with inflammatory arthritis: Secondary analyses based on the BIOlogical Dose OPTimisation (BIODOPT) trial.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 10, p. 3152, doi. 10.1111/bcp.15806

By:

Uhrenholt, Line;
Duch, Kirsten;
Christensen, Robin;
Dreyer, Lene;
Hauge, Ellen‐Margrethe;
Schlemmer, Annette;
Taylor, Peter C.;
Kristensen, Salome

Publication type:

Article

5

Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial.

Published in:

Rheumatology International, 2024, v. 44, n. 10, p. 1897, doi. 10.1007/s00296-024-05665-7

By:

Uhrenholt, Line;
Sørensen, Mads E. R.;
Lauridsen, Karen B.;
Duch, Kirsten;
Dreyer, Lene;
Christensen, Robin;
Hauge, Ellen-Margrethe;
Loft, Anne Gitte;
Rasch, Mads N. B.;
Horn, Hans Christian;
Taylor, Peter C.;
Nielsen, Kaspar R.;
Kristensen, Salome

Publication type:

Article

6

Isolation in patients with inflammatory rheumatic diseases during COVID-19 pandemic compared to healthy individuals: a questionnaire survey.

Published in:

Rheumatology International, 2022, v. 42, n. 5, p. 783, doi. 10.1007/s00296-022-05111-6

By:

Eriksen, Tobias Eschricht;
Dinesen, Wilfred K. H.;
Uhrenholt, Line;
Dreyer, Lene;
Duch, Kirsten;
Kristensen, Salome

Publication type:

Article